NOVARTIS VENTURE FUND
Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program. We prefer to have our initial investment at the early stage to build the company and follow with additional investment ... in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. Sectors New therapeutics & platforms Medical devices/implants Diagnostics/biomarkers Drug delivery/biopolymers Geography USA/Canada Europe Switzerland Asia/Pacific
NOVARTIS VENTURE FUND
Industry:
Finance Therapeutics Venture Capital
Founded:
1996-01-01
Status:
Active
Contact:
877 280 2296
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Universal Analytics DigiCert SSL GlobalSign Domain Verification Proofpoint Imperva Bot Detection And Mitigation
Similar Organizations
ABB Technology Ventures
ABB Technology Ventures (ATV) is the strategic venture capital unit of ABB (NYSE: ABB).
ALSA Ventures
ALSA Ventures invest in biotechnology companies passionate about bringing novel therapies to patients.
BB Biotech Ventures
BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices.
Civilization Ventures
Civilization Ventures is a venture capital firm focused on cutting edge innovations in exponential health tech and biology.
Claris Ventures
Claris Ventures is a venture capital firm focused on early-stage investments in high potential biopharma companies.
Digitalis Ventures
Digitalis is a venture capital firm that that invests in solutions to complex problems in human and animal health.
EIR Ventures
EIR Ventures is a new Life Science Venture Group in the Nordics.
Forward Ventures
Forward Ventures ic a venture capital company that focuses in companies in the area of biological sciences.
Founders Fund
Founders Fund is a venture capital firm investing in companies building revolutionary technologies.
Hikma Ventures
Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.
Kibo Ventures
Kibo Ventures is a venture capital fund investing in early-stage internet and mobile companies.
LocalGlobe
LocalGlobe is a venture capital firm that focuses on seed and impact investments.
Novalis LifeSciences
Novalis Lifesciences is a globally acting venture capital firm focused on breakthrough technologies in Life Science.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Samsung Ventures
Samsung Ventures is a venture capital firm specializing in investments in start-up companies.
TA Ventures
TA Ventures is a VC firm backing ambitious founders of technology companies across Europe, North America and beyond.
Union Square Ventures
Union Square Ventures is a venture capital firm that focuses on early-stage, growth-capital, late-stage, and startup financing.
VentureFriends
VentureFriends is a venture capital fund that invests in tech-enabled companies.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
2021-01-01
Board_member
Board_member
Advisor
Current Employees Featured
Spyros Artavanis-Tsakonas Chairman, Option Fund @ Novartis Venture Fund
Chairman, Option Fund
Lauren Silverman Managing Director @ Novartis Venture Fund
Managing Director
2006-01-01
Bart Dzikowski Managing Director, Head of Transactions & Legal @ Novartis Venture Fund
Managing Director, Head of Transactions & Legal
2009-01-01
Harry Kirsch Chief Financial Officer @ Novartis Venture Fund
Chief Financial Officer
Michal Silverberg Managing Director @ Novartis Venture Fund
Managing Director
2017-01-01
Laura Brass Managing Director @ Novartis Venture Fund
Managing Director
2018-10-01
David Morris Operating Partner @ Novartis Venture Fund
Operating Partner
2020-01-01
Hidde Ploegh Director- Option Fund @ Novartis Venture Fund
Director- Option Fund
Aaron Nelson Principal & Managing Director @ Novartis Venture Fund
Principal & Managing Director
2017-04-01
Florent Gros Managing Director @ Novartis Venture Fund
Managing Director
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-02 | Epsilogen | Novartis Venture Fund investment in Series B - Epsilogen | 30.75 M GBP |
| 2022-02-15 | Splice Bio | Novartis Venture Fund investment in Series A - Splice Bio | 50 M EUR |
| 2022-01-20 | ImmPACT Bio | Novartis Venture Fund investment in Series B - ImmPACT Bio | 111 M USD |
| 2021-12-28 | IKAS Industrial Automation | Novartis Venture Fund investment in Series B - IKAS Industrial Automation | 100 M CNY |
| 2021-12-16 | Anaveon | Novartis Venture Fund investment in Series B - Anaveon | 110 M CHF |
| 2021-11-23 | LOQUS23 THERAPEUTICS | Novartis Venture Fund investment in Seed Round - LOQUS23 THERAPEUTICS | 7 M GBP |
| 2021-11-15 | Kedalion Therapeutics | Novartis Venture Fund investment in Series B - Kedalion Therapeutics | N/A |
| 2021-10-05 | Exo Therapeutics | Novartis Venture Fund investment in Series B - Exo Therapeutics | 78 M USD |
| 2021-09-29 | Expansion Therapeutics | Novartis Venture Fund investment in Series B - Expansion Therapeutics | 80 M USD |
| 2021-09-15 | Flywheel.io | Novartis Venture Fund investment in Series C - Flywheel.io | 22 M USD |
More informations about "Novartis Venture Fund"
Novartis Venture Fund Team - nvfund.com
The Novartis Venture Fund Team is made up of people with proven expertise and talent in bringing exciting new drugs and treatments to patients all over the world. Drawing on …See details»
Biopharma/Biotech Investment | Novartis Venture Fund
The Novartis Venture Fund team’s approach to investing We prefer an active, hands-on style of investment, one major element of which involves taking a seat on the company board. This …See details»
Novartis Venture Fund - Crunchbase Investor Profile
Novartis Venture Fund prefers to have their initial investment at the early stage to build the company and follow with additional investment in pace with the company's progress. Their approach involves larger focused investments, with …See details»
Novartis Venture Fund - Private Equity International
Novartis Venture Fund News, insights, analysis and data Founded in 1996, Novartis Venture Fund is a Switzerland based investment organisation that focuses on the healthcare sector, …See details»
Novartis Venture Fund investment portfolio | PitchBook
Aug 19, 2024 Novartis Venture Fund's latest investment was on 19-Dec-2024 in Alesta Therapeutics, a company within the Drug Discovery industry. Data Transparency. Meet our …See details»
Novartis Venture Fund - Investments, Portfolio & Company Exits
Sep 9, 2020 Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms. New. ... Novartis Venture Fund has made 41 diversity …See details»
Novartis Venture Fund (NVF) - Life-Sciences-Europe.com
Organisation › Details Novartis Venture Fund (NVF) https://www.nvfund.com. The Novartis Venture Funds, established in 1996 currently manage over $750 million in committed capital. …See details»
Novartis Venture Fund - Investor Profile, Portfolio & Team - Tracxn
5 days ago Novartis Venture Fund is a venture capital firm founded in 1996.It is primarily based out of Basel, Switzerland. As of Jan 2025, Novartis Venture Fund is an active investor, having …See details»
Novartis Venture Fund - Contacts, Employees, Board Members
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Novartis Venture Fund - nvfund.com
Novartis Venture Fund investing in innovative life science companies for patient benefit, creating attractive returns for entrepreneurs and investors. Toggle navigation. Our Fund ... Our Fund …See details»
Novartis Venture Fund - Org Chart, Teams, Culture & Jobs - The Org
Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. In their investments, they look for unmet need and clinical impact, novel proprietary science, …See details»
Novartis Venture Fund - StartupHub.ai
Investments by the Novartis Venture Fund are made as equity participation typically as the lead or co-lead investor in a syndicate with a board seat. Date Founded: April 5, 1996. Total …See details»
Novartis Venture Fund - EU-Startups
Novartis Venture Fund’s primary focus is on the development of novel therapeutics and platforms. They balance the therapeutic focus with investments in medical devices, diagnostics, or drug …See details»
Meet Aaron Nelson | Novartis Venture Fund - nvfund.com
Prior to NVF, he was an investor at dRx Capital, a joint investment company of Novartis and Qualcomm, focused on Digital Medicine. Previously, Aaron worked on technology strategy …See details»
Novartis Venture Fund Portfolio Companies - Crunchbase
Jan 3, 2008 Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms. This list of organizations invested in by Novartis Venture …See details»
Novartis Venture Fund - Golden
Novartis Venture Fund. A corporate venture capital firm in Switzerland that focuses on companies that develop novel therapeutics and platforms. Overview Structured Data Issues Contributors …See details»
Mastering the Venture Capital Fund Audit: Essential Preparation …
May 23, 2024 Mastering the venture fund audit is a multifaceted endeavor that requires thorough preparation, a comprehensive understanding of the audit process, and meticulous attention to …See details»
Isomorphic Labs, Google’s A.I. Drug Business ... - The New York …
Mar 31, 2025 The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer. By Michael J. de la Merced …See details»
Novartis Venture Fund
Novartis Venture Fund has raised a total of $720M across 3 funds, their latest being Novartis Option Fund (NOF). This fund was announced on Jan 1, 2009 and raised a total of . ...See details»
IPO | Novartis Venture Fund - nvfund.com
Since its foundation in 1996, the Novartis Venture Fund has actively supported nearly 40 of its portfolio companies to access the public capital markets like the NASDAQ through a variety of …See details»